What is RetinAI Discovery?
RetinAI Discovery stands at the forefront of healthcare innovation, offering a comprehensive data management and analysis platform specifically designed for ophthalmology. The platform seamlessly integrates multiple data formats, from DICOM-compliant imaging to proprietary formats, while providing advanced AI-powered analysis capabilities for disease progression and treatment outcomes.
The platform features CE-marked AI models for OCT analysis, layer and fluid segmentation, and supports various ophthalmological conditions including AMD, DR, DME, CME, and GA. With its cloud-based infrastructure, the system enables secure global collaboration, real-time data monitoring, and automated biomarker analysis, serving both clinical practice and research environments.
Features
- AI Analysis: CE-marked biomarkers and automatic layer and fluid segmentation
- Data Integration: Support for multiple imaging formats and data types
- Secure Collaboration: GDPR, HIPAA & PIPEDA compliant platform
- Real-time Monitoring: Instant access to study progress and patient data
- Automated Biomarker Analysis: 30+ CE marked and Research Use Only biomarkers
- Natural Language Search: Advanced patient cohort identification
- Multi-center Management: Centralized data collection and analysis
- Disease-Specific Focus: Specialized tools for AMD, DR, DME, CME and GA
Use Cases
- Clinical trial data management
- Patient monitoring and disease progression tracking
- Multi-center research collaboration
- Real-world evidence generation
- Ophthalmology imaging analysis
- Tele-ophthalmology services
- Drug development research
- Clinical decision support
FAQs
-
What types of medical imaging formats does RetinAI Discovery support?
RetinAI Discovery supports DICOM-compliant formats, OCTs, Fundus images, PDFs, JPEG, PNG & TIFF files. -
What security compliance standards does the platform meet?
The platform is compliant with EU GDPR, HIPAA & Canadian PIPEDA rules for data privacy and security. -
What eye conditions can the AI models analyze?
The platform supports assessment of AMD, DR, DME, CME and GA (Geographic Atrophy) conditions.
